BTK acts as a modulator of the response to imatinib in chronic myeloid leukemiaLena Schmidlechner, Meike Kaehler|Oncology Letters|2024Cited by 1
Association of fibronectin 1 deregulation with tyrosine kinase inhibitor resistance in chronic myeloid leukemiaLina Tiedemann, Meike Kaehler|Frontiers in Cell and Developmental Biology|2025Cited by 1
The role of the lysine histone methylase KMT2D in chronic myeloid leukemiaLina Schlemminger, Meike Kaehler|Frontiers in Pharmacology|2025Cited by 0